Or it might be interesting to see what follows the interim Ph2 results that get shared in December!
My take on it - Gary is so confident from the Ph1 trial that showed efficacy, that he has no hesitation going blind on the Ph2 and committing to deliver the interim results in December. Then watch how the market reacts!
